Refalgin

CE medical device with mechanical action in the form of film-coated, swallowable tablets with rapid gastric dissolution.
Tablets containing alginate derived from seaweed, indicated for the treatment of gastric reflux to reduce associated symptoms. Can be used during continuous treatment with nonsteroidal anti-inflammatory drugs as primary prophylaxis for NSAID-induced gastropathy.

ingredients
Alginic acid 365 mg; sodium alginate 300 mg; calcium carbonate; maltodextrin; sodium chloride; microcrystalline cellulose; silicon dioxide; simethicone; hydrogenated vegetable fat; magnesium stearate; water; film coating: hydroxypropylcellulose.

How to use
Swallow 1-2 tablets after meals with a little water.
Wash your hands before and after using the medical device.
The duration of use depends on the evolution of symptoms; if necessary, Refalgin tablets can be administered for prolonged periods.

warnings
Do not use in case of individual hypersensitivity to one of the product components.
Safety during pregnancy and lactation has not been established. In such circumstances, it is recommended to consult your doctor.
There are no known interactions with other products, therefore it is advisable to consult your doctor before using Refalgin tablets in combination with other medical devices or medications.
Keep out of the reach and sight of children.

Conservation
Store the product tightly closed, in a cool, dry place.

Format
Box of 20 tablets of 1.3 g each.

CE marking registration number
0373